US Patent Issued to AEGIS THERAPEUTICS on June 10 for "Intranasal epinephrine formulations and methods for the treatment of disease" (California Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,838, issued on June 10, was assigned to AEGIS THERAPEUTICS LLC (San Diego).

"Intranasal epinephrine formulations and methods for the treatment of disease" was invented by Richard Lowenthal (San Diego), Edward T. Maggio (San Diego), Robert G. Bell (San Diego) and Pratik Shah (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Drug products adapted for nasal delivery comprising formulations with epinephrine and devices comprising such formulations are provided. Methods of treating anaphylaxis with epinephrine products are also provided."

The patent was filed on June 1, 2023, under Application No. 18/327,621.

*For further information, including...